D-0039-2022 Class II Terminated
FDA drug recall D-0039-2022 was initiated by First Royal Care Co. LLC, Dba Red Mountain Compounding Pharmacy on Aug 13, 2021 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns The recall status is terminated (terminated Apr 12, 2023).
Recall details
- Product Type
- Drugs
- Report Date
- Nov 3, 2021
- Initiation Date
- Aug 13, 2021
- Termination Date
- Apr 12, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Reason for recall
Distribution pattern
494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.
Code information
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0039-2022
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for First Royal Care Co. LLC, Dba Red Mountain Compounding Pharmacy? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.